EUVIMEDEUVIMED entdecken
Systematische Übersicht

Focused ultrasound-mediated blood-brain barrier opening to enhance temozolomide delivery in glioblastoma: a systematic review of preclinical and early clinical evidence

Joyce Campos, Max Schreiber, Nikki Barrington, Bryanna Rather Eguh, Shoaib A Syed, John A Boockvar, Randy S D'Amico

Neurosurgical Review · 2026

DOI: 10.1007/s10143-026-04367-x ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neurosurgical Review, 2026. Verfasst von Joyce Campos und 6 weiteren Autor:innen. Beteiligte Einrichtung: San Juan Bautista School of Medicine, Caguas, PR, USA. joycec@sanjuanbautista.edu. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Blood-Brain Barrier, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most aggressive primary malignant brain tumor in adults, with persistently poor survival despite chemoradiation and temozolomide (TMZ). Limited intratumoral drug delivery imposed by the blood-brain barrier (BBB), along with intrinsic and acquired resistance mechanisms, constrains TMZ efficacy. Focused ultrasound (FUS)-mediated BBB opening (BBBO) has emerged as a noninvasive strategy to transiently and locally enhance central nervous system drug delivery. To systematically synthesize preclinical and early clinical evidence evaluating the feasibility, safety, and therapeutic impact of FUS-enhanced TMZ delivery in GBM, and to identify key methodological and translational gaps informing future study design. A systematic search of PubMed, Cochrane Library, ClinicalTrials.gov, Embase, and Scopus was conducted from inception through December 2025. Eligible studies combined FUS-mediated BBBO with systemic TMZ in preclinical GBM models or human patients and reported pharmacologic, therapeutic, or safety outcomes. Nine studies (6 preclinical, 3 clinical) met inclusion criteria. All studies employed microbubbles to facilitate BBBO. Preclinical studies consistently demonstrated increased intratumoral TMZ delivery, improved tumor control, and prolonged survival with FUS plus TMZ compared with TMZ alone. Two studies directly quantified enhanced intratumoral drug exposure. Clinical studies demonstrated reproducible, MR-guided BBBO with favorable safety profiles and no procedure-related neurological complications. However, survival and pharmacokinetic endpoints remain preliminary. Focused ultrasound-mediated BBBO is a feasible and well-tolerated strategy to augment TMZ delivery in GBM. While preclinical evidence supports enhanced intratumoral drug exposure and therapeutic benefit, clinical efficacy remains unproven. Future studies should prioritize standardized protocols, direct pharmacokinetic validation, and adequately powered trials incorporating molecular stratification and clinically meaningful endpoints.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaBlood-Brain BarrierBrain NeoplasmsAntineoplastic Agents, AlkylatingDrug Delivery SystemsHumansAnimalsMicrobubbles

Stichwörter der Autor:innen

Blood-brain-barrierFocused ultrasoundGlioblastomaMicrobubblesTemozolomide

Substanzen

TemozolomideAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • San Juan Bautista School of Medicine, Caguas, PR, USA. joycec@sanjuanbautista.edu.
  • San Juan Bautista School of Medicine, Caguas, PR, USA.
  • Department of Neurosurgery, Chicago Medical School at Rosalind Franklin University, North Chicago, IL, USA.
  • Touro College of Osteopathic Medicine, Middletown, NY, USA.
  • Northwell, New Hyde Park, NY, USA.
  • Department of Neurosurgery, Lenox Hill Hospital, New York, NY, USA.

Zitieren

APA

Campos, J., Schreiber, M., Barrington, N., Eguh, B. R., Syed, S. A., Boockvar, J. A., & D'Amico, R. S. (2026). Focused ultrasound-mediated blood-brain barrier opening to enhance temozolomide delivery in glioblastoma: a systematic review of preclinical and early clinical evidence. Neurosurgical Review. https://doi.org/10.1007/s10143-026-04367-x

Vancouver

Campos J, Schreiber M, Barrington N, Eguh BR, Syed SA, Boockvar JA, et al. Focused ultrasound-mediated blood-brain barrier opening to enhance temozolomide delivery in glioblastoma: a systematic review of preclinical and early clinical evidence. Neurosurgical Review. 2026. doi:10.1007/s10143-026-04367-x

BibTeX
@article{Campos2026,
  author = {Campos, Joyce and Schreiber, Max and Barrington, Nikki and Eguh, Bryanna Rather and Syed, Shoaib A and Boockvar, John A and D'Amico, Randy S},
  title = {Focused ultrasound-mediated blood-brain barrier opening to enhance temozolomide delivery in glioblastoma: a systematic review of preclinical and early clinical evidence},
  journal = {Neurosurgical Review},
  year = {2026},
  doi = {10.1007/s10143-026-04367-x}
}
Kostenlos starten →